R&D Costs of New Medicines: A Landscape Analysis
Over the years, questions have been raised over R&D costs of new medicines. The aim of this study is to conduct a landscape review of the (drivers of) R&D costs of a new medicine derived from the peer-reviewed and grey literature. Included studies have drawn data either from confiden...
Main Authors: | Steven Simoens, Isabelle Huys |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.760762/full |
Similar Items
-
The Market of Biopharmaceutical Medicines: A Snapshot of a Diverse Industrial Landscape
by: Evelien Moorkens, et al.
Published: (2017-06-01) -
Cost Estimation Methods of Machine Elements at the Design Stage in Unit and Small Lot Production Conditions
by: Więcek Dorota, et al.
Published: (2019-03-01) -
Misinterpretation of the strategic significance of cost driver analysis: evidence from management accounting theory and practice
by: Henry T Palowski
Published: (2011-06-01) -
Questioning the cost/effectiveness of the R & D procurement process.
by: Roberts, Edward Baer.
Published: (2009) -
Questioning the cost/effectiveness of the R & D procurement process.
by: Roberts, Edward Baer.
Published: (2009)